The immune system can be tricky, and vaccine history is replete with surprising results that were completely unexpected at the time.
Good news is that with this vaccine, the immune system seems to prefer a little primer followed by a full booster, which will allow us to vaccinate more people with the same amount of vaccine. I don't have access to the company data, but i suspect the smaller priming dose was also likely better tolerated. So it is a win-win.
Since this vaccine is also not a brand-new technology, it may help allay the fears of people who are wary of the Pfizer and Moderna vaccines because of the newness factor.
Finally, this vaccine appears to be a lot easier logistically, with tolerance of higher temperatures and maintenance of potency for a much longer time.
I suspect this vaccine will see a lot of international use, especially in poorer countries, because of the stability factor.
All in all, more good news on the vaccine front.
We did half-dose flu vaccine followed by another half-dose one month later for children under the age of 9 for years and years. I can’t think of any where we started with a half-dose and then did a full dose later, but I can’t think of any reason to worry about it; seems preferable to having to have a full dose primer followed by a full-dose booster, to me.
Priming and boosting is a well understood mechanism of the way the immune system works. We don’t need prime-boosting for influenza vaccines because everybody has either been infected or vaccinated previously.
"We are not provided with wisdom, we must discover it for ourselves, after a journey through the wilderness which no one else can take for us, an effort which no one can spare us, for our wisdom is the point of view from which we come at last to regard the world." --M. Proust
Good article on the AstraZenica vaccine, comparing it to the other two that have reported results thus far. https://www.vox.com/21590994/oxford-...pfizer-moderna
The White House is using the Abbott Labs quick test which they still think is a gold standard. It is not. It gives a false sense of security. They test all visitors but it misses a good chuck of infected people. Duke uses pcr testing. Also the White House doesn't have required scheduled testing for people working there. They are also lax on testing people who work in the administration but not in the WH daily. Comparing what Duke is doing and the White House's halve baked scheme is an insult to Duke.
I previously posted this:https://www.latimes.com/science/stor...its-doors-open
Duke did / does some good things, WH not so much.
This is why we are in so much trouble now. How do we change these attitudes?!?!?
https://abc11.com/health/1-in-3-pare...id-19/8199644/
Not surprising and not encouraging. Some have pandemic fatigue and some have pandemic denial.
I'm reminded of the Chipmunks song of the season, though I may not have the lyrics exactly right.
Vaccine, vaccine time is near
Time for shots and time for cheer
We've been good but we can't last
Hurry vaccine, hurry fast
Does anyone know if the three vaccines at issue have been tested on diabetics? I have a family member for which that is an important issue. Thanks in advance!
We are on the precipice of a humanitarian crisis the likes of which we have not seen in a century in this country.
That it's arriving during the holidays, without a functioning federal government, a month away from 20 million Americans getting vaccinated, with billions in federal supports about to dry up, is a perverse collision of circumstances.
I think that something like 10% of the US population has diabetes. If so, I would find it very hard to believe that they would put tens of thousands of people through a vaccine trial and not end up with hundreds of diabetic folks taking the drug. They are looking for a representative sample of the population (with a slight oversampling in some groups that have been particularly susceptible to this virus), the notion that you would exclude 10% of the population from that sample seems bonkers to me and is enough of a deep flaw in the methodology that I think we would have heard about it by now.
Why are you wasting time here when you could be wasting it by listening to the latest episode of the DBR Podcast?
I haven't done any research into the matter, but as a diabetic(type 1, so far less prevalent and entirely possible not having been part of the trials)with kidney issues(including a stint on dialysis), I will be early in line for the vaccine(hyperactive/compromised immune system and all).
Early indication I saw on the news last night is that holiday air travel is down about 60% from last year, which isn't as good as it should be.